Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Nicole Fawcett photo
Hazard and doctors
Health Lab
Attacking ‘Invisible Threat’ that Affects Cancer Care Workers
Exposure to chemotherapy can create hazards for nurses, pharmacists as they deliver lifesaving care to patients, but use of protective devices remains low.
Medicine at Michigan
Residency or a Family?
How inconsistent parental leave policies affect residents
Brain graphic
Health Lab
Tackling Tumors That Always Come Back: New Brain Cancer Research Could Improve Outcomes
A genetic mutation makes a glioma subtype resistant to radiation, but a new study finds a potential way around it using currently available drugs.
Doctor with patient
Health Lab
Some Primary Care Doctors Not Prepared to Help with Cancer Treatment Decisions
Up to 1/3 of primary care providers discussed breast cancer treatment options with patients but many report gaps in their knowledge.
Health Lab
Circular RNA Holds Promise as Cancer Biomarker
The stable structure of circRNA makes it an ideal candidate for biomarkers. In addition, this type of RNA can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
Health Lab
New Patient Privacy Rules Could Disrupt Critical Research
In a new paper, researchers and ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect.
Health Lab
Acupressure Relieves Breast Cancer Treatment Symptoms, Study Finds
Breast cancer survivors reported improvements in depression, pain, anxiety and sleep after self-administered acupressure.
Health Lab
Genetic Testing Doesn't Cause Undue Worry for Breast Cancer Patients
Newer genetic tests introduce more ambiguity, but a new study finds patients are not overreacting to uncertain results.
Health Lab
Woman’s Rare Diagnosis Prompts Sweeping Treatment to Target Cysts
HIPEC, a procedure that combines surgery and heated chemotherapy, gave Melissa Hough peace of mind after hundreds of cysts were removed from her abdomen.
Health Lab
Genome Offers Clues to Esophageal Cancer Disparity
A genomic duplication may help explain why esophageal adenocarcinoma is much more common in Caucasians and presents a potential target for prevention.
Health Lab
Medical Training or a Family? Residents, Training Programs Seek Balance
As residency programs struggle to balance the well-being of trainees and the need to provide ample training, a new study finds inconsistent parental leave policies.
Health Lab
Why Many Older Patients with Low Risk Still Want Colorectal Cancer Screenings
A study of colonoscopy recipients finds mixed feelings about using age, life expectancy and risk calculators to guide screening. How doctors can steer the conversation.
Medicine at Michigan
New Subtype of Prostate Cancer
A new subtype occurs in 7 percent of patients
Health Lab
Major Strides in Pancreatic Cancer Give ‘Actual Reasons for Hope’
More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.
News Release
U-M cancer researcher awarded $6.5M Outstanding Investigator Award to explore precision oncology
As researchers gain more understanding of how to target cancer treatment to specific genetic markers, identifying the best, most “actionable” markers is crucial.
  • 5
  • 6
  • 7